[ST15] Short talk 15

[ST15-02（2P-388）] Pharmacological inhibition of BMI1 activates the p53 pathway and exerts antitumour effects on MYCN-amplified neuroblastoma

^○Masahiro Hirayama¹, Eri Yamada¹, Hiromasa Aoki¹, Kazuya Izumi¹, Ayumi Amano¹, Kohki Toriuchi¹, Koichi Ogami², Mai Nagasaka³, Yasumichi Inoue³, Hidetoshi Hayashi³, Satoru Takeshita^1,4, Hiroki Kakita^1,4, Yasumasa Yamada⁴, Mineyoshi Aoyama¹ (1.Department of Pathobiology, Graduate School of Pharmaceutical Sciences, Nagoya City University, 2.Division of Molecular Oncology, Center for Neurological Diseases and Cancer, Graduate School of Medicine, Nagoya University, 3.Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, 4.Department of Perinatal and Neonatal Medicine, Aichi Medical University)

Login required to view

Login is required to view some content.

Log in